Search Tag: Scott Schobel
2022 03 Oct
Dr. Schobel joins Vico from Roche where he was the clinical science leader for tominersen being developed for Huntington’s disease Vico Therapeutics B.V., a neurology-focused genetic medicine company announced the appointment of Scott Schobel, MD as chief medical officer. Dr. Schobel brings significant drug development experience to Vico, including...Read more